OGI — ORGANIGRAM GLOBAL INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1620737 ·
Ontario, Canada
Last close
$0.71
Market Cap
$101.90M
52W High
$2.24
52W Low
$0.69
ADV30
553,528
Next earnings
2026-12-15
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 105,782,000 | 41,422,000 | 5,330,000 | 105,538,000 | 820,262,000 | 10,851,000 | 334,800,000 |
| Mar 2026 | 59,794,000 | 16,407,000 | -9,793,000 | -921,000 | 521,312,000 | 4,292,000 | 149,500,000 |
| Dec 2025 | 63,538,000 | 23,315,000 | -3,418,000 | 19,969,000 | 530,673,000 | 7,576,000 | 161,217,000 |
| Sep 2025 | 80,061,000 | 31,838,000 | 1,189,000 | -37,964,000 | 562,211,000 | 28,200,000 | 213,081,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-50,217,000
Investing CF
$-129,606,000
Financing CF
$83,657,000
CapEx
$-18,528,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.86
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-484,141,000
Inventory
$165,056,000
Receivables
$88,605,000
ST Investments
$816,000
EBIT TTM
$-6,692,000
Pretax Income TTM
$81,271,000
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$309,175,008
EBITDA
$16,427,000
Free Cash Flow
$-1,246,500
Enterprise Value
$239,098,816
Total Cash
$11,667,000
Total Debt
$31,652,000
Shares Out
144,152,692
Trailing EPS
$0.44
Book Value
$2.61
ROE
17.6%
ROA
-0.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 259,183,000 | -15,300,000 | -24,759,000 | 562,211,000 | 213,081,000 | 349,130,000 | -7,591,000 |
| Sep 2024 | 159,841,000 | -34,756,000 | -45,440,000 | 407,860,000 | 101,871,000 | 305,989,000 | 3,872,000 |
| Aug 2022 | 145,809,000 | -38,752,000 | -14,283,000 | 577,107,000 | 69,049,000 | 508,058,000 | -36,211,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.02
Max Pain — expiry 2027-03-19
max pain strike: $1.00 · spot: $0.68 · call oi: 3,966 · put oi: 552
Expected Move to 2027-03-19:
±$0.45
(65.73%) —
implied range
$0.23 –
$1.12
· ATM straddle on $1.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| UNCY | Unicycive Therapeutics, Inc. | $101.35M | $3.70 | — |
| NERV | Minerva Neurosciences, Inc. | $103.13M | $2.16 | — |
| IMUX | IMMUNIC, INC. | $100.01M | $7.33 | — |
| CATX | Perspective Therapeutics, Inc. | $103.84M | $0.86 | — |
| EQ | Equillium, Inc. | $99.61M | $1.21 | — |
News headlines (Yahoo Finance, 1h cache)
Organigram Provides NASDAQ Listing Update
2026-11-13 23:00 · Yahoo
Organigram CEO Isn’t Worried About Curaleaf’s Threat to Top Its Aurora Bid
2026-11-10 19:24 · Yahoo
Aurora Cannabis Record International Medical Revenue – Quarterly Update Report
2026-11-09 23:37 · Yahoo
Aurora Cannabis Announces Fiscal 2027 Second Quarter Results
2026-11-05 12:05 · Yahoo
Aurora Cannabis Stock: What Organigram's Buyout Means for Investors
2026-11-04 13:32 · Yahoo
The Battle for the Biggest Weed Merger Ends in Canada
2026-11-03 23:55 · Yahoo
Organigram outbids Curaleaf with C$561M deal for Aurora Cannabis
2026-11-03 17:00 · Yahoo
Organigram Global to Acquire Aurora Cannabis for CA$7.80 per Common Share
2026-11-03 16:50 · Yahoo
Organigram Swoops In To Acquire Aurora Cannabis, Topping Curaleaf’s Rival Bid – ACB Stock Surges To Over 10-Month Highs
2026-11-03 16:40 · Yahoo
Canadian Investment Regulatory Organization Trade Resumption - OGI
2026-11-03 15:16 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.